These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6423392)

  • 1. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
    Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of the myeloma-associated membrane antigen KMA.
    Goodnow CC; Raison RL
    J Immunol; 1985 Aug; 135(2):1276-80. PubMed ID: 3925006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody with selectivity for human kappa myeloma and lymphoma cells which has potential as a therapeutic agent.
    Walker KZ; Boux HA; Hayden GE; Goodnow CC; Raison RL
    Adv Exp Med Biol; 1985; 186():833-41. PubMed ID: 3931433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor-associated antigen specific for human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Hayden GE; Basten A
    J Exp Med; 1983 Nov; 158(5):1769-74. PubMed ID: 6195295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of an epitope on human free kappa-light chains and on a cytoplasmic component in activated T cells.
    Walker KZ; Hayden GE; Goodnow CC; Boux HA; Adams E; Basten A; Raison RL
    J Immunol; 1985 Feb; 134(2):1059-64. PubMed ID: 2578149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide.
    Asvadi P; Cuddihy A; Dunn RD; Jiang V; Wong MX; Jones DR; Khong T; Spencer A
    Br J Haematol; 2015 May; 169(3):333-43. PubMed ID: 25653020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
    Sieverts H; Alabaster O; Goldschmidts W; Magrath I
    Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
    Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
    Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
    Hagner G
    Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The analysis of immunoregulation of idiotype synthesis by monoclonal anti-idiotypic antibody].
    Fujisaku A
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):134-45. PubMed ID: 3084367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
    Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
    Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia.
    Fukushima PI; Nguyen PK; O'Grady P; Stetler-Stevenson M
    Cytometry; 1996 Dec; 26(4):243-52. PubMed ID: 8979022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies.
    Babusíková O; Stevulová L
    Neoplasma; 2004; 51(6):422-30. PubMed ID: 15640950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
    Haegert DG
    Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane associated free kappa light chains are found on a subset of tonsil and in vitro-derived plasmablasts.
    Hutchinson AT; Jones DR; McCauley Winter P; Tangye SG; Raison RL
    Hum Immunol; 2014 Sep; 75(9):986-90. PubMed ID: 25149546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.